Clinical Trial Update: A Cross Sectional Evaluation of the Development in Children Age 4 to 7 Infected or Exposed to HIV From the ANRS 12140 Cohort (Pediacam) [NA]

View source ↗

Summary

Observational cross-sectional evaluation of development in children aged 4 to 7 who are HIV-infected or HIV-exposed from the ANRS 12140 Pediacam cohort. The stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Exposure
• HIV Infection

Snippet

Sponsor: ANRS, Emerging Infectious Diseases | Conditions: HIV, HIV-uninfected Children | NA | Status: UNKNOWN